Testing hydrocortisone dosing during newborn cooling
Treatments studied
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This Phase 4 trial studies the best way to give hydrocortisone (a steroid medicine) to newborns who are being cooled for a specific kind of birth-related lack of oxygen. It’s for babies who have low blood pressure during cooling, aiming to improve their stability while they receive standard treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby was born at 36 weeks of pregnancy or later
- Baby is receiving whole-body cooling (hypothermia) as part of standard care
- Baby currently has low blood pressure (mean arterial pressure below the gestational age in weeks)
- The care team believes hydrocortisone is needed during cooling
- Baby has an arterial line (umbilical or peripheral) to collect blood samples without extra needle sticks
- Parents give written consent for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a medication called sildenafil (commonly used for blood pressure) to standard cooling treatment can improve brain recovery in newborn babies with brain injury from lack of oxygen. It aims to see if the combination is safe and effective in helping these babies develop better.
This study compares different approaches to “cooling” treatment in newborns with mild hypoxic-ischemic encephalopathy (mild brain injury from not enough oxygen around birth). The goal is to see which approach works best and is safest for babies like yours.
This Phase 3 trial tests whether giving stress-dose hydrocortisone can improve outcomes for children with septic shock in the pediatric intensive care unit (PICU). It is designed for children who are already receiving strong medicines to support blood pressure because of a serious infection.
This trial studies whether cooling a newborn's body after a difficult birth helps prevent brain damage. Researchers will track babies treated with this cooling therapy and use brain imaging to see how well it works.
This study tests two different pain medicines (dexmedetomidine and morphine) given to newborns during cooling therapy, which is a treatment to help reduce brain injury. The goal is to see which medicine works better for comfort and safety.
This Phase 3 study tests whether cooling a newborn’s body can help babies with mild brain injury after a difficult birth. It aims to see if cooling improves brain-related outcomes compared with standard care.
Hear when a new Hypoxic-Ischemic Encephalopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.